Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach

Journal of Acquired Immune Deficiency Syndromes

Volumn 53, Issue 3, 2010, Pages 405-411

  Geng, Elvin H ^a,f   Bangsberg, David R ^c,f   Musinguzi, Nicolas ^d,f   Emenyonu, Nneka ^c,f   Bwana, Mwebesa Bosco ^d,f   Yiannoutsos, Constantin T ^e,f   Glidden, David V ^b,f   Deeks, Steven G ^a,f   Martin, Jeffrey N ^a,b,f  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^e INDIANA UNIVERSITY   (United States)

^f Evaluate AIDS   (United States)

Author keywords

Africa; Antiretroviral scale up; Losses to follow up,monitoring and evaluation; Sampling studies

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICA; AGE; ARTICLE; CD4 LYMPHOCYTE COUNT; CENTRAL NERVOUS SYSTEM DISEASE; COHORT ANALYSIS; CULTURAL FACTOR; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTENSION; INCIDENCE; INTERVIEW; LOST TO FOLLOW UP; MAJOR CLINICAL STUDY; MALE; MONEY; MORTALITY; PATIENT TRANSPORT; PRIORITY JOURNAL; RESPONSIBILITY; SOCIAL ASPECT; STATISTICAL ANALYSIS; SURVIVAL RATE; UGANDA;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; PATIENT DROPOUTS; TREATMENT OUTCOME; UGANDA;

EID: 77649224899     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181b843f0     Document Type: Article

References (24)

1. Stringer JS, Zulu I, Levy J, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA. 2006; 296:782-793.
2. Severe P, Leger P, Charles M, et al. Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med. 2005;353:2325-2334.
3. Wools-Kaloustian K, Kimaiyo S, Diero L, et al. Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. AIDS. 2006;20:41-48
4. Office of the Unites States Global AIDS Coordinator. The Power of Partnerships: The President's Emergency Plan for AIDS Relief Fifth Annual Report to Congress. Available at http://www.pepfar.gov/press/ fifth-annual-report/ index.htm. Accessed 30 March 2009.
5. RosenS,Fox MP, Gill CJ. Patient retentionin antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007;4:e298.
6. Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817-824.
7. Bisson GP, Gaolathe T, Gross R, et al. Overestimates of survival after HAART: implications forglobal scale-up efforts. PLoS ONE. 2008;3:e1725.
8. Geng EH, Emenyonu N, Bwana MB, et al. Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA. 2008;300:506-507.
9. Yu JK, Chen SC, Wang KY, et al. True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bull World Health Organ. 2007;85:550-554.
10. Brinkhof MW, Dabis F, Myer L, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008;86:559-567.
11. Dalal RP, Macphail C, Mqhayi M, et al. Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2008;47: 101-107.
12. Maskew M. Gender Differences in HIV Outcomes in South African Patients Receiving Highly Active Antiretroviral Therapy. HIV/AIDS Implementer's Meeting, Kampala, Uganda; 2008. Abstract no. 1511.
13. 3. HIV/AIDS Implementer's Meeting. Kampala, Uganda; 2008. Abstract no. 1621.
14. Pujades-Rodriguez M, O'Brien D, Humblet P, et al. Second-line anti-retroviral therapy in resource-limited settings: the experience of Medecins Sans Frontieres. AIDS. 2008;22:1305-1312.
15. Mamlin BW, Biondich PG, Wolfe BA, et al. Cooking up an open source EMR for developing countries: OpenMRS-a recipe for successful collaboration. AMIA Annu Symp Proc. 2006;2006:529-533.
16. Coviello V, Boggess, M. Cumulative incidence estimation in the presence of competing risks. Stata J. 2004;4:103-112.
17. Hess KR. Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med. 1995;14:1707-1723.
18. van Oosterhout JJ, Bodasing N, Kumwenda JJ, et al. Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi. Trop Med Int Health. 2005;10:464-470.
19. Mermin J, Were W, Ekwaru JP, et al. Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-unin-fected children: a prospective cohort study. Lancet. 2008;371:752-759.
20. Bangsberg DR, Ware N, Simoni JM. Adherence without access to anti-retroviral therapy in sub-Saharan Africa? AIDS. 2006;20:140-1; author reply 141-142.
21. Amico KR, Toro-Alfonso J, Fisher JD. An empirical test of the information, motivation and behavioral skills model of antiretroviral therapy adherence. AIDS Care. 2005;17:661-673.
22. Anglaret X, Toure S, Gourvellec G, et al. Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2004;35:320-323.
23. Brinkhof MW, Pujades-Rodriguez M, et al. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE. 2009;4:e5790.
24. Gerver S, Chadborn, T, Ibrahim, F, et al. HIV-Positive Patient Retention in the UK: High Rate of Loss to Clinical Follow-Up Among Patients From a London Clinic. IAS 2008. Mexico City, Mexico. Abstract no. TUAB0205.